Save
Email
Print
Share
RSSBrowse News Stories
41 to 50 of 76 stories
view headlines only
-
Variation In Genetic Make-Up Determines Each Person's Reaction To Popular Painkillers
January 5, 2006 — A study published in the January issue of the American Gastroenterological Association (AGA) journal Gastroenterology found a difference in how people responded to popular painkillers and that up to ... > full story -
Most NSAIDs Raise Risk Of Death After Heart Attack
November 14, 2005 — Taking either COX-2 inhibitors or other non-steroidal anti-inflammatory drugs (NSAIDs) after a heart attack, especially in high doses, increases the risk of death, researchers reported at the ... > full story -
Aspirin Might Prevent Vioxx Cardiac Damage
September 14, 2005 — Low-dose aspirin might prevent the cardiovascular damage known to arise from use of the painkiller rofecoxib (Vioxx®), suggest new findings from mouse studies by Duke University Medical Center ... > full story -
Long-Term Aspirin Use May Incur Risk
June 3, 2005 — Women who take ibuprofen or aspirin daily for several years might face a higher risk of certain breast cancers, according to preventive medicine researchers in the Keck School of Medicine of the ... > full story -
Penn Study Points To How COX-2 Inhibitors Can Eventually Lead To Heart Disease
May 25, 2005 — University of Pennsylvania School of Medicine researchers have found additional evidence that may help explain how selective inhibitors of COX-2 might predispose individuals to heart disease and ... > full story -
Two Drugs Combined More Cost-Effective Safer For Managing Arthritis In High-Risk Patients
May 9, 2005 — A new UCLA study shows that for arthritis sufferers at high-risk for gastrointestinal problems, the most cost-effective safer treatment is a common painkiller combined with an acid-reducing drug. ... > full story -
FDA Announces Series Of Changes To The Class Of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
April 19, 2005 — The Food and Drug Administration (FDA) has announced a series of important changes pertaining to the marketing of the non-steroidal anti-inflammatory class of drugs, including COX-2 selective and ... > full story -
Study Shows Common Painkillers Combined With Acid-Reducing Drugs More Cost-Effective, Safer For Managing Arthritis In High-Risk Patients
April 11, 2005 — Amid the recent controversy and confusion over serious side effects from pain medications, a new UCLA and Veterans Affairs Greater Los Angeles Healthcare System study demonstrates that for arthritis ... > full story -
Celebrex Provides A Two Pronged Attack Against Prostate Cancer
March 9, 2005 — Celecoxib, a selective COX-2 inhibitor with promising anti-cancer properties, has now been found to attack prostate cancer cells in a second way that differs from Vioxx (rofecoxib), another ... > full story -
COX-2 Inhibitors Associated With Blood Pressure Elevation
February 18, 2005 — An analysis of 19 randomized controlled trials involving COX-2 inhibitors (selective cyclooxygenase-2 inhibitors) suggests that these agents raise blood pressure more than either conventional ... > full story
Search ScienceDaily
Number of stories in archives: 140,690
more 
